Department of Management, Bar-Ilan University, 52900, Ramat-Gan, Israel.
BMC Public Health. 2023 Feb 14;23(1):328. doi: 10.1186/s12889-023-15203-y.
Immediately after Pfizer announced encouraging effectiveness and safety results from their COVID-19 vaccine clinical trials in 5- to 11-year-old children, this study aimed to assess parents' perceptions and intention to vaccinate their 5-11-year-old children and to determine socio-demographic, health-related, behavioral factors, as well as the role of incentives.
A cross-sectional online survey of parents of children between 5 and 11 years of age among the Jewish population in Israel (n = 1,012). The survey was carried out between September 23 and October 4, 2021, at a critical time, immediately after Pfizer's announcement. Two multivariate regressions were performed to determine predictors of parents' intention to vaccinate their 5-11-year-old children against COVID-19.
Overall, 57% of the participants reported that they intend to vaccinate their 5-11-year-old children against COVID-19 in the winter of 2022. 27% noted that they would vaccinate their 5-11-year-old children immediately; 26% within three months; and 24% within more than three months. Perceived susceptibility, benefits, barriers and cues to action, as well as two incentives - vaccine availability and receiving a "Green Pass" - were all significant predictors. However, Incentives such as monetary rewards or monetary penalties did not increase the probability of parents' intention to vaccinate their children. Parental concerns centered around the safety of the vaccine, fear of severe side effects, and fear that clinical trials and the authorization process were carried out too quickly.
This study provides data on the role of incentives in vaccinating 5-11-year-old children, how soon they intend to do so, and the predictors of those intentions, which is essential knowledge for health policy makers planning vaccination campaigns.
辉瑞公司宣布其 COVID-19 疫苗在 5 至 11 岁儿童临床试验中取得令人鼓舞的有效性和安全性结果后，本研究旨在评估家长对为其 5 至 11 岁儿童接种疫苗的看法和意愿，并确定社会人口统计学、与健康相关的、行为因素，以及激励措施的作用。
这是一项针对以色列犹太人群体中 5 至 11 岁儿童的父母的横断面在线调查（n=1012）。调查于 2021 年 9 月 23 日至 10 月 4 日进行，此时正值辉瑞宣布消息的关键时期。进行了两次多变量回归分析，以确定父母为其 5-11 岁儿童接种 COVID-19 疫苗的意愿的预测因素。
总体而言，57%的参与者表示他们打算在 2022 年冬季为其 5-11 岁的孩子接种 COVID-19 疫苗。27%的人表示他们会立即为其 5-11 岁的孩子接种疫苗；26%的人会在三个月内接种；24%的人会在三个月以上接种。感知易感性、益处、障碍和行动提示，以及两个激励措施——疫苗的可获得性和获得“绿色通行证”，都是显著的预测因素。然而，激励措施，如金钱奖励或金钱惩罚，并没有增加父母为孩子接种疫苗的意愿的可能性。家长的担忧主要集中在疫苗的安全性、对严重副作用的恐惧，以及担心临床试验和授权过程进行得太快。
本研究提供了关于激励措施在为 5-11 岁儿童接种疫苗中的作用、他们打算何时接种疫苗以及这些意图的预测因素的数据，这是为计划疫苗接种活动的卫生政策制定者提供的重要知识。
